Skip to content
Inciteful Med

Signs, Symptoms, and the Diagnostic Journey

Last updated:

Autosomal Dominant Cerebellar Ataxia (ADCA), also known as Spinocerebellar Ataxia (SCA), primarily causes progressive balance, speech, and coordination issues. Because standard genetic tests often miss the condition, patients must specifically request an SCA repeat expansion panel for an accurate diagnosis.

Key Takeaways

  • • The earliest signs of ADCA and SCA typically involve gait ataxia, slurred speech, and abnormal eye movements.
  • • Non-motor symptoms can include cognitive challenges, REM sleep behavior disorder, and sensory nerve changes.
  • • SCA is frequently misdiagnosed as Parkinson's disease or MSA-C due to overlapping symptoms and similar MRI results.
  • • Standard whole exome sequencing genetic tests often fail to detect the specific genetic mutations that cause most SCAs.
  • • A targeted SCA repeat expansion panel is the gold standard required to accurately diagnose spinocerebellar ataxia.

The journey to a diagnosis of Autosomal Dominant Cerebellar Ataxia (ADCA) or Spinocerebellar Ataxia (SCA) is often long and confusing. Because these conditions are rare and share symptoms with more common neurological disorders, many patients spend years seeing different specialists before finding the right answer. Understanding the symptoms and the specific tools needed for diagnosis can help you navigate this process more effectively.

The Symptoms: More Than Just Balance

While the hallmark of ADCA is ataxia (a lack of coordination), the condition affects much more than just how you walk.

Core Motor Symptoms

These are typically the first signs that lead a person to seek medical advice:

  • Gait Ataxia: A “drunken” or stumbling walk, often requiring a wider stance for balance [1][2].
  • Dysarthria: Slurred, slow, or “scanning” speech where the rhythm is disrupted [1].
  • Oculomotor Deficits: Changes in eye movement, such as nystagmus (involuntary jumping of the eyes) or difficulty following a moving object [3].

Non-Motor and “Extra-Cerebellar” Signs

As the condition progresses, or even before balance issues begin, other systems can be involved [4]:

  • CCAS (Cerebellar Cognitive Affective Syndrome): Often called “Schmahmann Syndrome,” this involves difficulties with executive functions (planning, multi-tasking), language, and regulating emotions [5][6].
  • Sleep Disturbances: Many patients experience REM Sleep Behavior Disorder (acting out dreams) or excessive daytime sleepiness [7][8].
  • Movement Disorders: Some types of SCA involve dystonia (involuntary muscle contractions), parkinsonism (tremors and stiffness), or myoclonus (sudden muscle jerks) [9][10].
  • Sensory Changes: Depending on the specific gene, some may experience hearing loss, vision loss, or “pins and needles” sensations (neuropathy) [11][12].

Why Misdiagnosis is Common

It is common for patients to be initially diagnosed with other conditions. This happens because the brain changes seen on an MRI in SCA can look remarkably similar to other diseases [13].

  • MSA-C (Multiple System Atrophy - Cerebellar Type): This condition often causes the same balance issues and even the same “hot cross bun sign” on an MRI as certain SCAs [13][14].
  • Parkinson’s Disease: Because some SCAs cause tremors and stiffness, they are frequently mistaken for Parkinson’s in the early stages [15][16].
  • Idiopathic Ataxia: This is simply a label meaning “ataxia of unknown cause,” often given when standard tests come back negative [17].

The Diagnostic “Gold Standard”: Repeat Expansion Testing

The most critical thing to understand about your diagnostic journey is that standard genetic tests often miss the most common SCAs [18]. (Learn more in The Biology of ADCA: Why the Brain Changes).

Many doctors order a Clinical Exome Sequencing (CES) or Whole Exome Sequencing (WES). While these tests are powerful, they are technically “blind” to nucleotide repeat expansions—the genetic “stutter” that causes most cases of SCA [18][19].

To get a definitive answer, your neurologist must order a specific SCA Repeat Expansion Panel. This test uses specialized methods (like Repeat Primed PCR) to count the exact number of repeats in your DNA, which a standard exome test cannot do [20][21]. If you have had a “negative” genetic test but still have symptoms, it is worth asking if repeat expansions were actually tested.

Frequently Asked Questions

What are the first signs of spinocerebellar ataxia (SCA)?
The earliest signs typically involve motor control problems. These include a stumbling or 'drunken' walk (gait ataxia), slurred and slowed speech (dysarthria), and changes in eye movement such as involuntary jumping (nystagmus).
Why is SCA commonly misdiagnosed?
SCA is frequently misdiagnosed because its symptoms and brain imaging results can closely mimic other, more common neurological conditions. In the early stages, it is often mistaken for Parkinson's disease, Multiple System Atrophy (MSA-C), or idiopathic ataxia.
Does a standard genetic test check for SCA?
Standard genetic tests, such as clinical or whole exome sequencing, often miss the specific genetic 'stutter' (nucleotide repeat expansions) that cause most SCAs. To get a definitive answer, your doctor must order a targeted SCA Repeat Expansion Panel.
Besides balance issues, what other symptoms can ADCA cause?
Beyond balance and motor issues, ADCA can cause sleep disturbances like acting out dreams, nerve pain, vision or hearing loss, and involuntary muscle contractions. Some patients also experience cognitive and emotional changes.
What is Cerebellar Cognitive Affective Syndrome (CCAS)?
CCAS, sometimes referred to as Schmahmann Syndrome, is a condition associated with cerebellar disease. It causes difficulties with executive functions like planning and multitasking, language processing, and regulating emotions.

Questions for Your Doctor

  • • Did my genetic testing specifically include 'repeat expansion' analysis for common SCAs (like SCA1, 2, 3, 6, 7), or was it a standard exome sequence?
  • • Could my symptoms be a 'mimic' of another condition like MSA-C or Parkinson's, and how have you ruled those out?
  • • Does my MRI show specific signs like 'pontine atrophy' or the 'hot cross bun sign,' and what does that mean for my diagnosis?
  • • Can you assess me for Cerebellar Cognitive Affective Syndrome (CCAS) using a specialized tool like the CCAS-Scale?
  • • Based on my genetic results, what extra-cerebellar symptoms (like vision loss, neuropathy, or sleep issues) should we be monitoring for?

Questions for You

  • • Have I noticed changes in my mood, personality, or ability to plan complex tasks that I haven't mentioned to my doctor?
  • • Do I experience vivid dreams, acting out dreams in my sleep, or sudden daytime sleepiness?
  • • What were the very first signs I noticed—was it balance, or something else like vision changes or slurred speech?
  • • Has my diagnosis changed over time (e.g., from 'idiopathic ataxia' to something else)?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias.

    Buijsen RAM, Toonen LJA, Gardiner SL, van Roon-Mom WMC

    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2019; (16(2)):263-286 doi:10.1007/s13311-018-00696-y.

    PMID: 30607747
  2. 2

    Spinocerebellar ataxia type 23 (SCA23): a review.

    Wu F, Wang X, Li X, et al.

    Journal of neurology 2021; (268(12)):4630-4645 doi:10.1007/s00415-020-10297-5.

    PMID: 33175256
  3. 3

    Visual oculomotor abnormalities and vestibulo‑ocular reflex dynamics in polyglutamine spinocerebellar ataxias (Review).

    Peng Y, Tu Q, Han Y, et al.

    Experimental and therapeutic medicine 2023; (26(1)):358 doi:10.3892/etm.2023.12057.

    PMID: 37324515
  4. 4

    A combination of chlorzoxazone and folic acid improves recognition memory, anxiety and depression in SCA3-84Q mice.

    Marinina KS, Bezprozvanny IB, Egorova PA

    Human molecular genetics 2024; (33(16)):1406-1419 doi:10.1093/hmg/ddae079.

    PMID: 38727562
  5. 5

    Cognitive, Emotional, and Other Non-motor Symptoms of Spinocerebellar Ataxias.

    Lin CR, Kuo SH, Opal P

    Current neurology and neuroscience reports 2024; (24(3)):47-54 doi:10.1007/s11910-024-01331-4.

    PMID: 38270820
  6. 6

    Translation, Cross-Cultural Adaptation, and Validation to Brazilian Portuguese of the Cerebellar Cognitive Affective/Schmahmann Syndrome Scale.

    de Oliveira Scott SS, Pedroso JL, Elias VV, et al.

    Cerebellum (London, England) 2023; (22(2)):282-294 doi:10.1007/s12311-022-01391-7.

    PMID: 35305246
  7. 7

    NREM-related parasomnias in Machado-Joseph disease: clinical and polysomnographic evaluation.

    Silva GM, Pedroso JL, Dos Santos DF, et al.

    Journal of sleep research 2016; (25(1)):11-5 doi:10.1111/jsr.12330.

    PMID: 26359123
  8. 8

    How specific are non-motor symptoms in the prodrome of Parkinson's disease compared to other movement disorders?

    Moscovich M, Heinzel S, Postuma RB, et al.

    Parkinsonism & related disorders 2020; (81()):213-218 doi:10.1016/j.parkreldis.2020.10.003.

    PMID: 33039276
  9. 9

    Movement Disorders in Autosomal Dominant Cerebellar Ataxias: A Systematic Review.

    Rossi M, Perez-Lloret S, Cerquetti D, Merello M

    Movement disorders clinical practice 2014; (1(3)):154-160 doi:10.1002/mdc3.12042.

    PMID: 30363920
  10. 10

    Genotype-phenotype correlations, dystonia and disease progression in spinocerebellar ataxia type 14.

    Chelban V, Wiethoff S, Fabian-Jessing BK, et al.

    Movement disorders : official journal of the Movement Disorder Society 2018; (33(7)):1119-1129 doi:10.1002/mds.27334.

    PMID: 29603387
  11. 11

    Autosomal dominant cerebellar ataxia, deafness, and narcolepsy (ADCA-DN) associated with progressive cognitive and behavioral deterioration.

    Walker LA, Bourque P, Smith AM, Warman Chardon J

    Neuropsychology 2017; (31(3)):292-303 doi:10.1037/neu0000322.

    PMID: 27869457
  12. 12

    Clinical and genetic analysis of spinocerebellar ataxia type 7 (SCA7) in Zambian families.

    Atadzhanov M, Smith DC, Mwaba MH, et al.

    Cerebellum & ataxias 2017; (4()):17 doi:10.1186/s40673-017-0075-5.

    PMID: 29214039
  13. 13

    An Update on Parkinson's Disease and its Neurodegenerative Counterparts.

    Adam H, Gopinath SCB, Arshad MKM, et al.

    Current medicinal chemistry 2024; (31(19)):2770-2787 doi:10.2174/0929867330666230403085733.

    PMID: 37016529
  14. 14

    A diagnostic decision tree for adult cerebellar ataxia based on pontine magnetic resonance imaging.

    Higashi M, Ozaki K, Hattori T, et al.

    Journal of the neurological sciences 2018; (387()):187-195 doi:10.1016/j.jns.2018.02.022.

    PMID: 29571861
  15. 15

    Long-term efficacy of bilateral subthalamic deep brain stimulation in the parkinsonism of SCA 3: A rare case report.

    Kuo MC, Tai CH, Tseng SH, Wu RM

    European journal of neurology 2022; (29(8)):2544-2547 doi:10.1111/ene.15339.

    PMID: 35837753
  16. 16

    Long-term globus pallidus internus deep brain stimulation in a young patient with spinocerebellar ataxia type 3 initially presenting with levodopa-responsive parkinsonism: a 6-year follow-up case report and literature review.

    Zhao J, Ma S, Gao Y, et al.

    Therapeutic advances in neurological disorders 2025; (18()):17562864251396525 doi:10.1177/17562864251396525.

    PMID: 41427024
  17. 17

    Natural History and Phenotypic Spectrum of GAA-FGF14 Sporadic Late-Onset Cerebellar Ataxia (SCA27B).

    Wirth T, Clément G, Delvallée C, et al.

    Movement disorders : official journal of the Movement Disorder Society 2023; (38(10)):1950-1956 doi:10.1002/mds.29560.

    PMID: 37470282
  18. 18

    Spinocerebellar Ataxia Tethering PCR: A Rapid Genetic Test for the Diagnosis of Spinocerebellar Ataxia Types 1, 2, 3, 6, and 7 by PCR and Capillary Electrophoresis.

    Cagnoli C, Brussino A, Mancini C, et al.

    The Journal of molecular diagnostics : JMD 2018; (20(3)):289-297 doi:10.1016/j.jmoldx.2017.12.006.

    PMID: 29462666
  19. 19

    Detection of ATXN2 Expansions in an Exome Dataset: An Underdiagnosed Cause of Parkinsonism.

    Casse F, Courtin T, Tesson C, et al.

    Movement disorders clinical practice 2023; (10(4)):664-669 doi:10.1002/mdc3.13699.

    PMID: 37070044
  20. 20

    Diagnostic Efficacy of Genetic Studies in a Series of Hereditary Cerebellar Ataxias in Eastern Spain.

    Baviera-Muñoz R, Carretero-Vilarroig L, Vázquez-Costa JF, et al.

    Neurology. Genetics 2022; (8(6)):e200038 doi:10.1212/NXG.0000000000200038.

    PMID: 36530930
  21. 21

    Prevalence of RFC1-mediated spinocerebellar ataxia in a North American ataxia cohort.

    Aboud Syriani D, Wong D, Andani S, et al.

    Neurology. Genetics 2020; (6(3)):e440 doi:10.1212/NXG.0000000000000440.

    PMID: 32582864

This page provides educational information about the symptoms and diagnosis of ADCA and SCA. It is not a substitute for professional medical advice, diagnosis, or genetic counseling. Always consult your neurologist regarding diagnostic testing.

Stay up to date

Get notified when new research about Autosomal dominant cerebellar ataxia is published.

No spam. Unsubscribe anytime.